The Asia Pacific bioplastics and biopolymers market is expected to grow from US$ 2,890.07 million in 2023 to US$ 6,171.13 million by 2030. It is estimated to grow at a CAGR of 11.4% from 2023 to 2030.
Conventional plastic is expected to become more expensive in the future with diminishing raw material sources. The PLA and its copolymers are used in various wound management applications, such as healing dental wounds, making surgical sutures, and preventing postoperative adhesions. PLA has also been implemented in the drug delivery system owing to its encapsulation capacity, low toxicity, and biocompatibility. Thus, all the aforementioned factors are estimated to offer lucrative opportunities for the bioplastics and biopolymers market over the coming years.
Based on product type, the Asia Pacific bioplastics and biopolymers market is segmented into polyethylene, polyethylene terephthalate, polylactic acid, polytrimethylene terephthalate, polybutylene adipate terephthalate, polybutylene succinate, cellulose, blends, and others. The blends segment accounted the largest share of the Asia Pacific bioplastics and biopolymers market in 2023.
Based o n end-use industry, the Asia Pacific bioplastics and biopolymers market is divided into packaging, consumer goods, automotive, textile, building and construction, medical, agriculture, and others. The packaging segment held the largest share of the Asia Pacific bioplastics and biopolymers market in 2023.
Based on country, the Asia Pacific bioplastics and biopolymers market is segmented int o Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific bioplastics and biopolymers market in 2023.
Arkema SA, BASF SE, Braskem SA, Cardia Bioplastics Australia Pty Ltd, Corbion NV, Eastman Chemical Co, Mitsubishi Chemical Holdings Corp, Mitsui Chemicals Inc, Novamont SpA, and Saudi Basic Industries Corp are some of the leading companies operating in the Asia Pacific bioplastics and biopolymers market.
Reasons to Buy
Growing Incorporation of Biodegradable Plastics in Biomedical Applications Drives Asia Pacific Bioplastics and Biopolymers Market
In the biomedical industry, bioplastics are highly applicable in skin replacements for burnings and wounds, scaffolds for tissue engineering, bone reconstruction, nerves and gum reconstruction, drugs releasing system, blood vessel growth and stent covering. Furthermore, nontoxic biodegradable bioplastics sutures, commonly referred to as stitches, are being used by medical professionals in hospitals and surgeries. Biodegradable plastics are also used for medical devices. For instance, pins, tacks, and screws, which are used to help bones heal during reconstructive surgery, are made with bioplastics. Containers for tablets and creams can also be produced utilizing bioplastic. Besides, in the dental industry, bioplastics-based nanocellulose has been used in dental tissue regeneration in humans, produced from microbial cellulose by the Glucanacetobacter xylinus strain. Biodegradable plastics such as PLA; PCL; poly lactic-co-glycolic acid (PLGA) and poly-hydroxyalkanoate (PHA), along with their copolymers, are applied in the human centric biomedical applications. For instance, PLA is widely used in medical applications owing to its biocompatibility and bio dissolvability in the human body by the hydrolysis of the ester backbone to produce non-harmful and nontoxic compounds after its degradation. PLA and its copolymers are also used in wound management applications that includes the manufacturing of surgical sutures, prevention of postoperative adhesions, and the healing of dental wounds. PLA is used in drug delivery systems considering its complete biodegradability, better encapsulation, biocompatibility, and low toxicity. Biodegradable plastics are also used in the orthopaedic applications to avoid a second surgical procedure to remove unnecessary hardware.Conventional plastic is expected to become more expensive in the future with diminishing raw material sources. The PLA and its copolymers are used in various wound management applications, such as healing dental wounds, making surgical sutures, and preventing postoperative adhesions. PLA has also been implemented in the drug delivery system owing to its encapsulation capacity, low toxicity, and biocompatibility. Thus, all the aforementioned factors are estimated to offer lucrative opportunities for the bioplastics and biopolymers market over the coming years.
Asia Pacific Bioplastics and Biopolymers Market Overview
The Asia Pacific bioplastics and biopolymers market is divided into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. Factors such as the growth of the packaging industry, governments' policies encouraging the adoption of environment-friendly products, rising environmental concerns, and growing investments by key market players are driving the bioplastics and biopolymers market growth in the region. Consumers are increasingly shifting toward bio-based plastics due to increasing environment-related regulations and government initiatives to encourage environmental awareness. The rising number of bans on traditional plastics proves to be the primary driver for regional market growth. As countries such as India and China are environmentally concerned, companies are shifting to bioplastics and biopolymers, which is anticipated to help them acquire a higher consumer market share.Asia Pacific Bioplastics and Biopolymers Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Bioplastics and Biopolymers Market Segmentation
The Asia Pacific bioplastics and biopolymers market is segmented into product type , end-use industry, and country.Based on product type, the Asia Pacific bioplastics and biopolymers market is segmented into polyethylene, polyethylene terephthalate, polylactic acid, polytrimethylene terephthalate, polybutylene adipate terephthalate, polybutylene succinate, cellulose, blends, and others. The blends segment accounted the largest share of the Asia Pacific bioplastics and biopolymers market in 2023.
Based o n end-use industry, the Asia Pacific bioplastics and biopolymers market is divided into packaging, consumer goods, automotive, textile, building and construction, medical, agriculture, and others. The packaging segment held the largest share of the Asia Pacific bioplastics and biopolymers market in 2023.
Based on country, the Asia Pacific bioplastics and biopolymers market is segmented int o Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific bioplastics and biopolymers market in 2023.
Arkema SA, BASF SE, Braskem SA, Cardia Bioplastics Australia Pty Ltd, Corbion NV, Eastman Chemical Co, Mitsubishi Chemical Holdings Corp, Mitsui Chemicals Inc, Novamont SpA, and Saudi Basic Industries Corp are some of the leading companies operating in the Asia Pacific bioplastics and biopolymers market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioplastics and biopolymers market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific bioplastics and biopolymers market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Asia Pacific Bioplastics and Biopolymers Market Landscape
5. Asia Pacific Bioplastics and Biopolymers Market - Key Market Dynamics
6. Bioplastics and Biopolymers Market - Asia Pacific Market Analysis
7. Asia Pacific Bioplastics and Biopolymers Market Analysis - Product Type
8. Asia Pacific Bioplastics and Biopolymers Market Analysis - End-Use Industry
9. Asia Pacific Bioplastics and Biopolymers Market - Country Analysis
10. Competitive Landscape
11. Industry Landscape
12. Company Profiles
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Arkema SA
- BASF SE
- Braskem SA
- Cardia Bioplastics Australia Pty Ltd
- Corbion NV
- Eastman Chemical Co
- Mitsubishi Chemical Holdings Corp
- Mitsui Chemicals Inc
- Novamont SpA
- Saudi Basic Industries Corp
